Endocrine-disrupting effects of bisphenols on urological cancers
Eve Pellerin1, Christophe Caneparo2, Stéphane Chabaud2
1Centre de Recherche en Organogénèse Expérimentale/LOEX, Regenerative Medicine Division, CHU de Québec-Université Laval Research Center, Québec, Canada; Intersectorial Centre for Endocrine Disruptors Analysis, Institut National de La Recherche Scientifique (INRS), Québec, Canada; ARThrite Research Center, Laval University, Québec, Canada.
Abstract:
Bisphenols are endocrine-disrupting chemicals found in a broad range of products that can modulate hormonal signalling pathways and various other biological functions. These compounds can bind steroid receptors, e.g. estrogen and androgen receptors, expressed by numerous cells and tissues, including the prostate and the bladder, with the potential to alter their homeostasis and normal physiological functions. In the past years, exposure to bisphenols was linked to cancer progression and metastasis. As such, recent pieces of evidence suggest that endocrine-disrupting chemicals can lead to the development of prostate cancer. Moreover, bisphenols are found in the urine of the wide majority of the population. They could potentially affect the bladder's normal physiology and cancer development, even if the bladder is not recognized as a hormone-sensitive tissue. This review will focus on prostate and bladder malignancies, two urological cancers that share standard carcinogenic processes. The description of the underlying mechanisms involved in cell toxicity, and the possible roles of bisphenols in the development of prostate and bladder cancer, could help establish the putative roles of bisphenols on public health.
Insights
Bisphenols, common endocrine-disrupting chemicals, may contribute to prostate and bladder cancer development. Understanding their mechanisms is crucial for public health.
Area of Science:
- Endocrinology
- Toxicology
- Urology
Background:
- Bisphenols are endocrine-disrupting chemicals (EDCs) prevalent in consumer products.
- They interfere with hormonal signaling, affecting tissues like the prostate and bladder.
- Exposure to bisphenols has been linked to cancer progression and metastasis.
Purpose of the Study:
- To review the role of bisphenols in the development of prostate and bladder cancers.
- To explore the mechanisms of bisphenol-induced cell toxicity in urological malignancies.
- To assess the public health implications of widespread bisphenol exposure.
Main Methods:
- Literature review focusing on endocrine-disrupting chemicals and urological cancers.
- Analysis of studies investigating bisphenol mechanisms of action.
- Synthesis of evidence linking bisphenol exposure to prostate and bladder carcinogenesis.
Main Results:
- Bisphenols can bind to estrogen and androgen receptors, potentially altering prostate and bladder homeostasis.
- Evidence suggests a link between EDC exposure and the development of prostate cancer.
- Bisphenols may impact bladder physiology and cancer development despite it not being a classical hormone-sensitive tissue.
Conclusions:
- Bisphenols play a potential role in the development of prostate and bladder cancers.
- Further research into the mechanisms of bisphenol toxicity is warranted.
- Understanding these roles is vital for public health strategies concerning EDC exposure.
Related Concept Videos
Oogenesis
Teratogenicity
Nursing Assessment of the Genitourinary System I: Health History
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Urinary Tract Infection II: Pathophysiology


